- Home
- RL vs DGX Comparison
RL vs DGX Comparison
Compare RL & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RL
- DGX
- Stock Information
- Founded
- RL 1967
- DGX 1967
- Country
- RL United States
- DGX United States
- Employees
- RL N/A
- DGX N/A
- Industry
- RL Apparel
- DGX Medical Specialities
- Sector
- RL Consumer Discretionary
- DGX Health Care
- Exchange
- RL Nasdaq
- DGX Nasdaq
- Market Cap
- RL 17.7B
- DGX 17.5B
- IPO Year
- RL 1997
- DGX 1996
- Fundamental
- Price
- RL $277.67
- DGX $172.26
- Analyst Decision
- RL Buy
- DGX Buy
- Analyst Count
- RL 11
- DGX 13
- Target Price
- RL $298.10
- DGX $177.69
- AVG Volume (30 Days)
- RL 821.2K
- DGX 1.2M
- Earning Date
- RL 02-06-2025
- DGX 01-30-2025
- Dividend Yield
- RL 1.19%
- DGX 1.86%
- EPS Growth
- RL 24.59
- DGX 2.67
- EPS
- RL 10.92
- DGX 7.69
- Revenue
- RL $6,949,600,000.00
- DGX $9,872,000,000.00
- Revenue This Year
- RL $6.67
- DGX $10.18
- Revenue Next Year
- RL $4.07
- DGX $3.82
- P/E Ratio
- RL $25.43
- DGX $22.40
- Revenue Growth
- RL 5.23
- DGX 6.70
- 52 Week Low
- RL $155.96
- DGX $123.66
- 52 Week High
- RL $289.33
- DGX $172.91
- Technical
- Relative Strength Index (RSI)
- RL 63.56
- DGX 70.79
- Support Level
- RL $262.93
- DGX $166.15
- Resistance Level
- RL $289.12
- DGX $172.64
- Average True Range (ATR)
- RL 8.04
- DGX 3.27
- MACD
- RL 1.05
- DGX 0.74
- Stochastic Oscillator
- RL 78.27
- DGX 94.96
About RL Ralph Lauren Corporation
Founded by designer Ralph Lauren in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.